In December, the FDA also released draft guidance for manufacturers on how to notify the agency about permanent or temporary interruptions in formula production. The draft aims to help manufacturers comply with the Federal Food, Drug, and Cosmetic Act during times of potential or actual supply disruptions.
By strengthening oversight and enhancing industry collaboration, the FDA aims to ensure a more reliable supply of infant formula for American families moving forward.
